300009 安科生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)3.60316.93517.98524.39523.461
总资产报酬率 ROA (%)2.98913.76414.01818.40317.746
投入资产回报率 ROIC (%)3.53016.56017.52223.68522.864

边际利润分析
销售毛利率 (%)75.59075.69877.39478.35378.406
营业利润率 (%)36.41231.62531.79732.24236.121
息税前利润/营业总收入 (%)36.32331.57731.59931.96835.668
净利润/营业总收入 (%)31.78128.23928.22729.96031.645

收益指标分析
经营活动净收益/利润总额(%)95.82697.32594.034101.66692.447
价值变动净收益/利润总额(%)2.5332.4113.232-0.5604.929
营业外收支净额/利润总额(%)-0.060-0.456-0.421-0.440-0.977

偿债能力分析
流动比率 (X)4.3013.7443.4082.7452.827
速动比率 (X)3.8313.3492.9632.4682.516
资产负债率 (%)13.41814.62416.26820.57120.089
带息债务/全部投入资本 (%)-1.590-1.639-1.573-1.701-2.329
股东权益/带息债务 (%)-6,160.035-5,977.090-6,203.621-5,718.036-4,160.325
股东权益/负债合计 (%)624.080561.818493.686366.977375.201
利息保障倍数 (X)-537.875329.333-488.601-240.501-347.433

营运能力分析
应收账款周转天数 (天)69.86657.83070.44859.99464.782
存货周转天数 (天)179.336153.942167.191129.323140.078